Skip to main content
. 2014 Jan 10;4(1):e173. doi: 10.1038/bcj.2013.71

Figure 5.

Figure 5

Figure 5

Clinical course of (a) two patients with NPM1mut (red) and low BAALC expression levels (blue) at diagnosis showing no difference in BAALC expression levels during the cause of the disease and (b) three patients with high BAALC expression levels (blue) at diagnosis concomitantly carrying FLT3-ITD (green), MLL-PTD and/or RUNX1mut (red) showing good concordance of these markers during follow-up.